Clinical Trial Update: Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy [NA]

View source ↗

Summary

A completed clinical trial study evaluated CyPass Micro-Stent implantation in patients with primary open-angle glaucoma refractory to topical therapy; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• CyPass Micro-Stent

Snippet

Sponsor: Transcend Medical, Inc. | Conditions: Primary Open Angle Glaucoma (POAG) | NA | Status: COMPLETED | Results posted: 2016-10-28